Somekh E, Levin M J
Pediatric Infectious Diseases, University of Colorado School of Medicine, Denver 80262.
J Med Virol. 1993 Jul;40(3):241-3. doi: 10.1002/jmv.1890400313.
The relative ability of a varicella-zoster virus (VZV) clinical isolate and a live attenuated VZV vaccine strain (Oka) to infect human neurons was determined in vitro. VZV infection of neurons prepared in culture from dorsal root ganglia of fetuses was assessed using an infectious center assay. Cultures were infected with 50-5,000 pfu of either VZV and assayed at either 24 or 48 hours post-VZV infection. Cultures infected with the clinical VZV isolate had seven-fold more infected neurons than cultures infected with the vaccine strain VZV.
在体外测定了水痘带状疱疹病毒(VZV)临床分离株和减毒活VZV疫苗株(Oka)感染人神经元的相对能力。使用感染中心试验评估了从胎儿背根神经节培养制备的神经元的VZV感染情况。用50 - 5000个蚀斑形成单位(pfu)的VZV感染培养物,并在VZV感染后24小时或48小时进行检测。感染临床VZV分离株的培养物中被感染的神经元数量比感染疫苗株VZV的培养物多7倍。